Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Inmed Medical Technology is a high-tech medical device company headquartered in Shanghai, China, specializing in the development of interventional vascular products. Established in 2016, the company focuses on providing innovative solutions for cardiovascular, peripheral vascular, and neurovascular interventions. Their product portfolio includes high-pressure balloon catheters, PTCA balloon catheters, and advanced drug-coated balloons designed for complex vascular procedures. Inmed operates a large-scale manufacturing facility that adheres to international quality management systems, ensuring high standards for its medical components. The company aims to replace imported high-end medical devices with domestically produced alternatives that offer comparable performance and safety. With a strong emphasis on R&D, Inmed continues to expand its pipeline to address unmet clinical needs in the field of minimally invasive surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上海英脉德医疗科技.